Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of Androgen and Estrogen in Growth Hormone-Treated Girls With Turner Syndrome
NCT00001343Phase 2Completed
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Dec 1992
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of oxandrolone and DehydraTECH-estrogen in Turner syndrome (TS) (2 arms), sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development. Primary endpoint: Growth Rate at 2 years. Started Dec 1992; status: completed.
02
Drugs
oxandroloneDehydraTECH-estrogen
03
Conditions
Turner syndrome (TS)
Beyond the preview
Go deeper on NCT00001343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001343.